[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629458":3},{"organization":4,"armGroups":7,"interventions":39,"overallOfficials":10,"centralContacts":10,"locations":81,"responsibleParty":271,"collaborators":10,"id":273,"slug":274,"hasResults":275,"nctId":276,"briefTitle":277,"officialTitle":278,"acronym":279,"eligibilityCriteria":280,"healthyVolunteers":275,"sex":281,"minAge":10,"maxAge":10,"enrollmentInfo":282,"targetDuration":285,"studyType":286,"phases":10,"briefSummary":287,"conditions":288,"keywords":298,"overallStatus":84,"whyStopped":10,"lastUpdateSubmitDate":309,"lastUpdatePostDateStruct":310,"startDateStruct":313,"completionDateStruct":315,"leadSponsor":317,"locationsCount":318},{"fullName":5,"class":6},"Phenox GmbH","INDUSTRY",[8,17,23,28,34],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment of Intracranial Aneurysm",null,"Patients undergoing treatment for intracranial aneurysms (IA) with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.\n\nThe cohort originates from one overarching registry protocol.",[13,14,15,16],"Device: Aneurysm Treatment with a Neurovascular Flow Diverter","Device: Aneurysm Treatment with Neurovascular Stent System","Device: Aneurysm treatment with Bifurcation Aneurysm Implant","Device: Aneurysm treatment with Avenir Coil System",{"label":18,"type":10,"description":19,"interventionNames":20},"Treatment of Vascular Dissection","Patients undergoing treatment for vascular dissection with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.\n\nThe cohort originates from one overarching registry protocol.",[21,22],"Device: Dissection Treatment with a Neurovascular Flow Diverter","Device: Dissection Treatment with Neurovascular Stent System",{"label":24,"type":10,"description":25,"interventionNames":26},"Treatment of Vascular Perforation","Patients undergoing treatment for vascular perforation with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.\n\nThe cohort originates from one overarching registry protocol.",[27],"Device: Perforation Treatment with a Neurovascular Flow Diverter",{"label":29,"type":10,"description":30,"interventionNames":31},"Treatment of Neurovascular Abnormalities","Patients undergoing treatment for neurovascular abnormalities with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.\n\nThe cohort originates from one overarching registry protocol.",[32,33],"Device: Arteriovenous Fistula treatment with a Neurovascular Flow Diverter","Device: Arteriovenous fistula treatment with Avenir Coil System",{"label":35,"type":10,"description":36,"interventionNames":37},"Treatment of Atherosclerotic Vascular Stenosis of Intracranial Arteries","Patients undergoing treatment for atherosclerotic vascular stenosis of intracranial arteries with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.",[38],"Device: Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System",[40,45,49,53,57,61,65,69,73,77],{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":10},"DEVICE","Aneurysm Treatment with a Neurovascular Flow Diverter","Treatment of aneurysms (saccular or fusiform) and pseudoaneurysms with a Neurovascular Flow Diverter. This includes p64, p64 MW, p64 MW HPC, p48 MW and p48 MW HPC.",[9],{"type":41,"name":46,"description":47,"armGroupLabels":48,"otherNames":10},"Dissection Treatment with a Neurovascular Flow Diverter","Treatment of vascular dissections in the acute and chronic phases with a Neurovascular Flow Diverter. This includes p64, p64 MW, p64 MW HPC, p48 MW and p48 MW HPC.",[18],{"type":41,"name":50,"description":51,"armGroupLabels":52,"otherNames":10},"Perforation Treatment with a Neurovascular Flow Diverter","Treatment of vascular perforations with a Neurovascular Flow Diverter. This includes p64, p64 MW, p64 MW HPC, p48 MW and p48 MW HPC.",[24],{"type":41,"name":54,"description":55,"armGroupLabels":56,"otherNames":10},"Arteriovenous Fistula treatment with a Neurovascular Flow Diverter","Treatment of Arteriovenous fistula with a Neurovascular Flow Diverter. This includes p64, p64 MW, p64 MW HPC, p48 MW and p48 MW HPC.",[29],{"type":41,"name":58,"description":59,"armGroupLabels":60,"otherNames":10},"Aneurysm Treatment with Neurovascular Stent System","Treatment of saccular and fusiform aneurysms as well as pseudoaneurysms with pEGASUS HPC. pEGASUS HPC is to be used in combination with coils.",[9],{"type":41,"name":62,"description":63,"armGroupLabels":64,"otherNames":10},"Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System","Atherosclerotic vascular stenosis of intracranial arteries treated with pEGASUS HPC.",[35],{"type":41,"name":66,"description":67,"armGroupLabels":68,"otherNames":10},"Dissection Treatment with Neurovascular Stent System","Treatment of vascular dissections in the acute and chronic phases with pEGASUS HPC.",[18],{"type":41,"name":70,"description":71,"armGroupLabels":72,"otherNames":10},"Aneurysm treatment with Bifurcation Aneurysm Implant","Treatment of intracranial bifurcation aneurysms with pCONUS 2 or pCONUS 2 HPC.",[9],{"type":41,"name":74,"description":75,"armGroupLabels":76,"otherNames":10},"Aneurysm treatment with Avenir Coil System","Treatment of intracranial aneurysms with the available variants of the Avenir Coil System.",[9],{"type":41,"name":78,"description":79,"armGroupLabels":80,"otherNames":10},"Arteriovenous fistula treatment with Avenir Coil System","Treatment of arteriovenous fistula with the available variants of the Avenir Coil System.",[29],[82,101,115,130,143,156,169,182,200,213,227,243,258],{"facility":83,"status":84,"city":85,"state":10,"zip":86,"country":87,"countryCode":88,"cosmosGeoPoint":89,"geoPoint":94,"contacts":95},"CHU Brest - Hôpital de La Cavale Blanche","RECRUITING","Brest","29200","France","FR",{"type":90,"coordinates":91},"Point",[92,93],-4.48628,48.39029,{"lat":93,"lon":92},[96],{"name":97,"role":98,"phone":99,"phoneExt":10,"email":100},"Jean-Christophe GENTRIC, Prof. Dr.","CONTACT","+33 2 98 34 74 87","jean-christophe.gentric@chu-brest.fr",{"facility":102,"status":103,"city":104,"state":10,"zip":105,"country":87,"countryCode":88,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Pitié Salpêtrière Hospital","NOT_YET_RECRUITING","Paris","75013",{"type":90,"coordinates":107},[108,109],2.3488,48.85341,{"lat":109,"lon":108},[112],{"name":113,"role":98,"phone":10,"phoneExt":10,"email":114},"Frédéric CLARENÇON, Prof. Dr.","frederic.clarencon@aphp.fr",{"facility":116,"status":103,"city":117,"state":10,"zip":118,"country":119,"countryCode":120,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"Helios Klinikum Erfurt","Erfurt","99089","Germany","DE",{"type":90,"coordinates":122},[123,124],11.03536,50.97734,{"lat":124,"lon":123},[127],{"name":128,"role":98,"phone":10,"phoneExt":10,"email":129},"Joachim KLISCH, Prof.","joachim.klisch@helios-gesundheit.de",{"facility":131,"status":103,"city":132,"state":10,"zip":133,"country":119,"countryCode":120,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Universitätsklinikum Hamburg-Eppendorf","Hamburg","20246",{"type":90,"coordinates":135},[136,137],9.99302,53.55073,{"lat":137,"lon":136},[140],{"name":141,"role":98,"phone":10,"phoneExt":10,"email":142},"Maxim BESTER, PD. Dr.","m.bester@uke.de",{"facility":144,"status":103,"city":145,"state":10,"zip":146,"country":119,"countryCode":120,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"University Hospital Heidelberg","Heidelberg","69120",{"type":90,"coordinates":148},[149,150],8.69079,49.40768,{"lat":150,"lon":149},[153],{"name":154,"role":98,"phone":10,"phoneExt":10,"email":155},"Markus MÖHLENBRUCH, Prof.","markus.moehlenbruch@med.uni-heidelberg.de",{"facility":157,"status":103,"city":158,"state":10,"zip":159,"country":119,"countryCode":120,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"LMU Klinikum","München","81377",{"type":90,"coordinates":161},[162,163],13.31243,51.60698,{"lat":163,"lon":162},[166],{"name":167,"role":98,"phone":10,"phoneExt":10,"email":168},"Thomas LIEBIG, Prof. Dr.","Thomas.Liebig@med.uni-muenchen.de",{"facility":170,"status":103,"city":171,"state":10,"zip":172,"country":119,"countryCode":120,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"Klinikum Nürnberg","Nuremberg","90471",{"type":90,"coordinates":174},[175,176],11.07752,49.45421,{"lat":176,"lon":175},[179],{"name":180,"role":98,"phone":10,"phoneExt":10,"email":181},"Markus HOLTMANNSPÖTTER, Dr.","Markus.Holtmannspoetter@klinikum-nuernberg.de",{"facility":183,"status":103,"city":184,"state":10,"zip":185,"country":186,"countryCode":187,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"Cannizzaro Hospital in Catania","Catania","95126","Italy","IT",{"type":90,"coordinates":189},[190,191],15.07041,37.49223,{"lat":191,"lon":190},[194,197],{"name":195,"role":98,"phone":10,"phoneExt":10,"email":196},"Guglielmo PERO, Dr.","Guglielmo.pero@gmail.com",{"name":198,"role":199,"phone":10,"phoneExt":10,"email":10},"Concetto CRISTAUDO, Prof.","SUB_INVESTIGATOR",{"facility":201,"status":103,"city":202,"state":10,"zip":203,"country":186,"countryCode":187,"cosmosGeoPoint":204,"geoPoint":208,"contacts":209},"ASST Grande Ospedale Metropolitano Niguarda, Milano","Milan","20162",{"type":90,"coordinates":205},[206,207],12.59836,42.78235,{"lat":207,"lon":206},[210],{"name":211,"role":98,"phone":10,"phoneExt":10,"email":212},"Mariangela PIANO, Dr.","mariangela.piano@ospedaleniguarda.it",{"facility":214,"status":103,"city":215,"state":10,"zip":216,"country":186,"countryCode":187,"cosmosGeoPoint":217,"geoPoint":221,"contacts":222},"Antonio Cardarelli Hospital- Naples","Naples","80131",{"type":90,"coordinates":218},[219,220],14.26811,40.85216,{"lat":220,"lon":219},[223,225],{"name":224,"role":98,"phone":10,"phoneExt":10,"email":10},"Mario MUTO, Prof.",{"name":226,"role":199,"phone":10,"phoneExt":10,"email":10},"Amedeo CERVO, Dr.",{"facility":228,"status":84,"city":229,"state":10,"zip":230,"country":231,"countryCode":232,"cosmosGeoPoint":233,"geoPoint":237,"contacts":238},"Univerzitná nemocnica L. Pasteura Košice","Košice","040 11","Slovakia","SK",{"type":90,"coordinates":234},[235,236],21.25802,48.71441,{"lat":236,"lon":235},[239],{"name":240,"role":98,"phone":241,"phoneExt":10,"email":242},"Piotr PEDOWSKI, Dr.","+42155640 4213","piotr.pedowski@unlp.sk",{"facility":244,"status":103,"city":245,"state":10,"zip":246,"country":247,"countryCode":248,"cosmosGeoPoint":249,"geoPoint":253,"contacts":254},"Universitätsspital Basel","Basel","4031","Switzerland","CH",{"type":90,"coordinates":250},[251,252],7.57327,47.55839,{"lat":252,"lon":251},[255],{"name":256,"role":98,"phone":10,"phoneExt":10,"email":257},"Marios-Nikos PSYCHOGIOS, Prof.","marios.psychogios@usb.ch",{"facility":259,"status":103,"city":260,"state":10,"zip":261,"country":247,"countryCode":248,"cosmosGeoPoint":262,"geoPoint":266,"contacts":267},"Kantonsspital St.Gallen","Sankt Gallen","9007",{"type":90,"coordinates":263},[264,265],9.37477,47.42391,{"lat":265,"lon":264},[268],{"name":269,"role":98,"phone":10,"phoneExt":10,"email":270},"Victoria HELLSTERN, Dr.","victoria.hellstern@h-och.ch",{"type":272,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100629458","targeting-real-world-usage-in-stroke-treatment-100629458",false,"NCT07474935","Targeting Real World Usage In Stroke Treatment","TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry","TRUST","Inclusion Criteria:\n\n* Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),\n* Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.\n\nExclusion Criteria:\n\n* Participation in an interventional study modifying standard care management for all relevant indications,","ALL",{"count":283,"type":284},5000,"ESTIMATED","5 Years","OBSERVATIONAL","TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.\n\nThe overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.",[289,290,291,292,293,294,295,296,297],"Saccular and Fusiform Aneurysms","Pseudoaneurysm","Vascular Dissection","Perforation","Bifurcation Aneurysms","Stenosis","Neurovascular Abnormalties","Wide-neck Aneurysm","Intracranial Aneurysms",[299,300,301,302,303,304,305,306,307,308],"TRUST Registry","Registry study","Flow Diverter","WallabyPhenox","p48 MW (HPC)","p64","Avenir Coil","p64 MW (HPC)","pEGASUS HPC","pCONUS 2 (HPC)","2026-03-11",{"date":311,"type":312},"2026-03-16","ACTUAL",{"date":314,"type":312},"2026-01-29",{"date":316,"type":284},"2041-01",{"name":5,"class":6},13]